BioRegion Real Estate


Citing Decline in Demand, Sanofi-Aventis Shutting Down KC Manufacturing Site

Sanofi-aventis US said this week it will close by mid-2012 a Kansas City, Mo., manufacturing site that mainly makes solid dose forms of oral medications, based on declining demand for the products in North America.

The company said in a statement it will close down the plant in phases stretching about two-and-a-half years, with additional details on the timetable and process to be disclosed by the end of November.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Labs in the US and South Korea are hoping to bring the woolly mammoth back from beyond extinction, Newsweek writes.

Geneticist Adam Rutherford speaks with National Geographic about paleogenetics, race, and more.

Researchers link genetic links between education and smoking and longevity.

In PNAS this week: influence of gene environment interactions on polygenic traits, epigenetic features affecting fruit fly foraging, and more.